Radiology, Vol 178, 95-99, Copyright © 1991 by Radiological Society of North America

ARTICLES

Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy

A DelMaschio, A Vanzulli, S Sironi, M Castrucci, R Mellone, C Staudacher, M Carlucci, A Zerbi, D Parolini and A Faravelli
Department of Radiology, University Hospital, Milan, Italy.

The authors prospectively performed serum CA 19-9 assessment, ultrasound (US), computed tomography (CT), and CT-guided fine-needle aspiration biopsy (FNAB) of the pancreas in 81 consecutive patients with suspected chronic pancreatitis or pancreatic neoplasm. The final diagnosis was pancreatic cancer in 54 patients and chronic pancreatitis in 27 patients. CA 19-9 assessment, US, CT, and FNAB were considered nondiagnostic, respectively, in 0%, 25%, 19%, and 6% of cases. When a definite diagnosis was rendered, the positive predictive value was 90% for CA 19-9 assessment, 95% for US, 98% for CT, and 100% for FNAB; the negative predictive value was, respectively, 69%, 95%, 86%, and 100%. The accuracy of all diagnostic and nondiagnostic studies was 81% for CA 19-9 assessment, 72% for US, 77% for CT, and 94% for FNAB. It is concluded that CT-guided pancreatic FNAB is the most reliable examination for enabling differential diagnosis of pancreatic cancer and chronic pancreatitis. When the pancreas is well visualized at US, the negative predictive value for pancreatic cancer is more accurate than that of CA 19-9 assessment and CT.

This article has been cited by other articles:

				C. von Forstner, J.-H. Egberts, O. Ammerpohl, D. Niedzielska, R. Buchert, P. Mikecz, U. Schumacher, K. Peldschus, G. Adam, C. Pilarsky, et al. Gene Expression Patterns and Tumor Uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an Orthotopic Mouse Xenotransplantation Model of Pancreatic Cancer J. Nucl. Med., August 1, 2008; 49(8): 1362 - 1370. [Abstract] [Full Text] [PDF]

				G. Cwik, G. Wallner, T. Skoczylas, A. Ciechanski, and K. Zinkiewicz Cancer Antigens 19-9 and 125 in the Differential Diagnosis of Pancreatic Mass Lesions Arch Surg, October 1, 2006; 141(10): 968 - 973. [Abstract] [Full Text] [PDF]

				S. D. Paulsen, H. V. Nghiem, E. Negussie, E. J. Higgins, E. M. Caoili, and I. R. Francis Evaluation of imaging-guided core biopsy of pancreatic masses. Am. J. Roentgenol., September 1, 2006; 187(3): 769 - 772. [Abstract] [Full Text] [PDF]

				M. K. Kalra, M. M. Maher, G. W. Boland, S. Saini, and A. J. Fischman Correlation of Positron Emission Tomography and CT in Evaluating Pancreatic Tumors: Technical and Clinical Implications Am. J. Roentgenol., August 1, 2003; 181(2): 387 - 393. [Full Text] [PDF]

				S. Tanaka, A. Nakaizumi, T. Ioka, O. Oshikawa, H. Uehara, M. Nakao, K. Yamamoto, O. Ishikawa, H. Ohigashi, and T. Kitamra Main Pancreatic Duct Dilatation: a Sign of High Risk for Pancreatic Cancer Jpn. J. Clin. Oncol., October 1, 2002; 32(10): 407 - 411. [Abstract] [Full Text] [PDF]

				M. Andrianifahanana, N. Moniaux, B. M. Schmied, J. Ringel, H. Friess, M. A. Hollingsworth, M. W. Buchler, J.-P. Aubert, and S. K. Batra Mucin (MUC) Gene Expression in Human Pancreatic Adenocarcinoma and Chronic Pancreatitis: A Potential Role of MUC4 as a Tumor Marker of Diagnostic Significance Clin. Cancer Res., December 1, 2001; 7(12): 4033 - 4040. [Abstract] [Full Text] [PDF]

				B. E. M. Van Driel, T. M. Van Gulik, P. D. J. Sturm, G. J. A. Offerhaus, D. J. Gouma, and C. J. F. Van Noorden Differential Diagnosis of Chronic Pancreatitis and Pancreatic Cancer in Brush Cytology Specimens Cancer Res., November 1, 1999; 59(22): 5732 - 5736. [Abstract] [Full Text] [PDF]

				P. T. Johnson and E. K. Outwater Pancreatic Carcinoma versus Chronic Pancreatitis: Dynamic MR Imaging Radiology, July 1, 1999; 212(1): 213 - 218. [Abstract] [Full Text]

				M. L. Steer, I. Waxman, and S. Freedman Chronic Pancreatitis N. Engl. J. Med., June 1, 1995; 332(22): 1482 - 1490. [Full Text] [PDF]